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Inadequate diabetes control is more
prevalent in South Asians than Europeans:
potential role of therapeutic inertia
SV Eastwood, AD Hughes, T Tillin and N Chaturvedi
Institute of Cardiovascular Sciences, University College London, London, UK
Refer to Oral number A14
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Disparities in the prescribing of DPP-4
inhibitors, SGLT2 inhibitors, and GLP-1
analogues in UK primary care
A McGovern, W Hinton, B Arrowsmith, N Munro, M Whyte
and S de Lusignan
Department of Clinical and Experimental Medicine, University of Surrey,
Guildford, UK
Aims: People with lower socioeconomic status (SES) and ethnic
minority groups have worse glycaemic control and higher inci-
dence of diabetes complications. We evaluated the use of newer
diabetes therapies (DPP-4 inhibitors, SGLT2 inhibitors, and GLP-1
analogues) across SES and ethnic groups to identify any disparities
in use which may be contributing to ongoing outcome disparities.
Methods: A cohort of people with Type 2 diabetes (N = 60,327)
was identified from the University of Surrey-Lilly Real World
Evidence database, using routinely collected primary care data.
The number of people initiated on new therapies over a 12 month
period (2015) was analysed. The impact of SES and ethnicity on
propensity to prescribe was investigated using logistic regression
adjusting for potential confounders (age, gender, glycaemic con-
trol, duration of diabetes, number of previous therapies, renal
function, and body mass index).
Results: We identified 2,599 people initiated on DPP-4 inhibitors,
1,118 on SGLT2 inhibitors, and 556 on GLP-1 analogues. After
adjusting for confounders there were no differences in prescribing
by SES. Compared to those of White ethnicity, there was reduced
propensity to prescribe SGLT2 inhibitors to those of Black (OR
0.48; 95% CI 0.32-0.71; p < 0.001) or Asian ethnicity (OR 0.61;
0.48-0.78; p < 0.001), and there was reduced propensity to
prescribe GLP-1 analogues to those of Asian ethnicity (OR 0.53;
0.35-0.81; p = 0.003). No significant difference in prescribing
propensity was found with DPP-4 inhibitors.
Conclusions: There was no association between prescribing newer
medications and SES. However, we found a strong interaction
between ethnic group and propensity to prescribe newer therapies.
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The management of hypertension in Afro-
Caribbean patients with Type 2 diabetes at a
large teaching primary care centre in
Birmingham
S Abdulrahman1, A Chauhan1 and MA Saeed2,3
1College of Medical and Dental Sciences, University of Birmingham,
Birmingham, UK, 2Department of Diabetes, University Hospitals Birmingham,
Birmingham, UK, 3School of Clinical and Experimental Medicine, University of
Birmingham, Birmingham, UK
Aims: Hypertension affects a third of the population in England,
with Afro-Caribbean people constituting a high-risk group. Due to
their differing pathophysiology, NICE guidance published in 2009
[CG87] and revised in 2015 [NG28] recommends that when living
with Type 2 diabetes they should be prescribed an angiotensin
converter enzyme inhibitor (ACEi) together with either a calcium
channel blocker (CCB) or diuretic as first-line therapy for hyper-
tension and reno-protection. We investigated whether the NICE
guidance on hypertension management is being adhered to in
people of Afro-Caribbean ethnicity living with Type 2 diabetes
(diagnosed since the introduction of the 2009 guideline) in a large
teaching primary care centre located in an ethnically diverse area of
Birmingham.
Methods: Using the EMIS electronic records, people matching the
above criteria were identified and the relevant data was collected.
Results: For the 60 patients identified, surprisingly only a third
(n = 20) were managed in-line with the guidance. Of the two-
thirds who were not, 90% (n = 36) had not been prescribed the
recommended combination. The remaining 10% (n = 4) had not
tolerated first-line therapy (hyperkalaemia, hypotension, and/or,
other adverse reactions). 26.7% (n = 16) of the sample had a sub-
optimal blood pressure, with 75% (n = 12) not having been
monitored within the recommended timeframe laid out by NICE.
Conclusion: Adherence to NICE guidance in relation to ethnic-
specific hypertension prescribing for patients with Type 2 diabetes
appears to be suboptimal in primary care. Knowledge of this aspect
of the guideline needs to be reinforced by diabetes organisations
and charities, e.g. Diabetes UK.
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Diabetes foot care: survey of practice in
primary care
S Kassim1, I McDermott1, B Power1, F Day1, M Greensmith2
and P Carder3
1Long Term Condition Clinical Network, NHS Leeds Clinical Commissioning
Group, Leeds, UK, 2Diabetes Clinical Network, NHS England, Willerby, UK,
3West Yorkshire Research and Development, NHS Bradford Districts Clinical
Commissioning Group, Bradford, UK
Aims: There is an inconsistency of competencies in delivery of
diabetic foot care in primary care. The aim of the study was to
determine the knowledge and practice of foot checks amongst
health professionals in primary care.
Methods: An anonymous questionnaire was completed by variety
of health professionals involving general practitioners, practice
nurses, advance nurse practitioners and health care assistants
working in primary care team in Leeds West CCG area. The survey
was conducted over three weeks.
Results: In total, out of the 65 health professionals participated in
the survey, 40% were GP practitioners, 28% practice nurses, 28%
health care assistants and the remaining 4% advance nurse practi-
tioners. The overall response rate of 16.5% was obtained based on
estimated number of workforce in primary care team in Leeds West
CCG.Nearly 30% involved in the diabetes foot care check never had
any formal training on conducting diabetes foot check. 31% of
correspondents never feel for foot pulses in a diabetes foot check.
71% of correspondents were not able to accurately identify local
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Leeds indications criteria for immediate referral to hospital multi-
disciplinary foot team. Amongst the various health professionals,
78% of health care assistants have never referred to the local
screening and pathway guidance for diabetic foot ulcers.
Conclusions: There are significant gaps in knowledge and quality
of diabetes foot checks in primary care team. There is an urgent
need for implementing a minimum core standard competencies and
training for non-specialists especially health care assistants
involved in diabetes care delivery including foot care.
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Daily treatment with the anabolic agent
recombinant human parathyroid hormone
does not enhance time to resolution,
fracture healing and resolution of bone
marrow oedema of the active Charcot foot:
results from a double blind randomised
placebo controlled investigator led clinical
trial
ME Edmonds1, W Tang1, M Bates1, T Jemmott1, V Morris1,
AN Donaldson1, C Moniz2, L Meacock3, D Elias3 and
NL Petrova1
1Diabetic Foot Clinic, King’s College Hospital NHS Foundation Trust, London,
UK, 2Department of Biochemsitry, King’s College Hospital NHS Foundation
Trust, London, UK, 3Department of Radiology, King’s College Hospital NHS
Foundation Trust, London, UK
Refer to Oral number A65
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The impact of pre-existing vascular
complications on mortality in patients with
diabetic foot ulcers
MP Thompson, FM Creagh, D Selvarajah and RA Gandhi
Academic Department of Diabetes, Endocrinology & Metabolism, Sheffield
Teaching Hospitals NHS Foundation Trust, Sheffield, UK
Introduction: It is recognised that the high levels of premature
mortality in patients with diabetic foot ulcers is predominantly
related to cardiovascular mortality. Many of these individuals have
evidence of pre-existing vascular complications. This study aimed
to investigate the impact that these complications on patient
mortality.
Methods: Patients (n = 300) were recruited at their first diabetic
foot clinic appointment with a new ulcer. Structured interviews
were performed to identify patients with a history of macrovas-
cular complications; classified as a history of MI, stroke, intermit-
tent claudication or absent foot pulses on clinical examination.
Twelve (n = 200) and 24 (n = 132) month outcomes were
prospectively assessed to compare mortality rates in patients with
and without macrovascular complications.
Results: At baseline 161 patients (53.7%) were classified as
having macrovascular disease. Of these, 101 (62.7%) had an
absent foot pulse, 52 (32.3%) had a history of MI, 40 (24.8%) a
history of stroke and 42 (26.1%) a history of intermittent
claudication. At 12 months there was a 3-fold increase in mortality
in patients with macrovascular complications compared with those
without (16.5% vs 5.6%, p = 0.016). At 24 months this increased
to a 6-fold increase (24.4% compared with 3.8%, p = 0.002).
Conclusions: In patients with diabetic foot ulcers, a history of
macrovascular complications was associated with substantially
higher rates of mortality. Active systematic identification of these
patients, which is not currently routine practice in most foot
clinics, would allow for more effective risk stratification and ensure
those at the highest risk of dying prematurely receive more
comprehensive clinical attention.
P332
Impact of the foot protection service on
outcomes in people with diabetic foot
ulcers
MP Thompson, FM Creagh, D Selvarajah, J Walker, D Sanger
and RA Gandhi
Academic Department of Diabetes, Sheffield Teaching Hospitals NHS
Foundation Trust, Sheffield, UK
Background and Aims: A cornerstone of the NICE guidelines on
diabetes foot care is the provision of a podiatry-led foot protection
service (FPS). Yet there is currently no published evidence on its
ability to reduce the incidence of diabetic foot ulcers and associated
complications. This study aimed to investigate the impact and
efficacy of the FPS on reducing these critical outcomes.
Methods: Patients (n = 300) were recruited during their first
diabetic foot clinic appointment with a new foot ulcer (stratified
into those with first ulcers and recurrent ulcers). Twelve (n = 200)
and 24 (n = 132) month outcomes were prospectively assessed to
compare healing times and complication rates (re-ulceration,
amputation, ulcer not healed at 1 year) between those attending
and not attending the FPS.
Results: Significantly fewer patients presenting with their first
ulcer were attending the FPS than those with recurrent ulcers
(63.9% vs 83.7%, p < 0.001). In patients presenting with first
ulcers, FPS attendance was associated with significantly shorter
healing times (12 months: median 9.0 vs 14.0 weeks, p = 0.049, 24
months: 7.0 vs 19.0 weeks, p = 0.003). FPS attendance was also
associated with fewer complications (complication free at
12 months: 78.6% vs 63.6%, p = 0.174, 24 months: 73.3% vs
40%, p = 0.03). No difference was seen in either outcome in those
with recurrent ulceration.
Conclusions: Over a third of patients presenting with a first ulcer
had not previously seen the FPS. In first ulcer patients, attendance
of the FPS is associated with faster healing and lower complication
rates. The FPS is less efficacious in those with recurrent ulceration.
P333
Implementation of a new diabetic foot
assessment tool: a pilot project
M Rahman, V Goulding, N Agarwal, B Gwillym, A Tabasum,
D Ershad and N Gill
Diabetes & Endocrinology, University Hospital LLandough, Cardiff, UK
Introduction: Around 5 million people will have diabetes by the
year 2025 in UK. At least 10% of the patient will have diabetic
foot disease in their life. It has significant mortality, morbidity and
cost implication. Within 5 years of developing a diabetic foot ulcer
mortality rate is about 50%. Recent data from NADIA showed
that foot protection is not up to the required standard across UK.
In light of that we have developed a foot protection tool to improve
the assessment of patients who are at risk of foot disease.
Methodology: The tool was based on the ‘Foot of bed form’
devised by Dr Gerry Rayman, IpswichHospital. It was imple-
mented as a pilot project in the diabetic ward of University hospital
of LLandough for 16 weeks and acute admission unit for 2 weeks.
Patients with a known diagnosis of diabetes were only included in
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the data collection. Ward based presentation, practical demon-
stration, 1-to-1 support, e-learning tool, pocket card guide were
provided prior to the intervention. Audit process was based on the
NADIA audit.
Result: A baseline inpatient data prior to intervention showed
20% patient (total number 2) had a completed foot assessment. At
the end of 16 weeks following implementation of tool, 80% (total
number 10) of patients have their foot assessment completed. In
acute admission 66 patients were identified and 33% (19) have
their assessment completed during their admission.
Conclusion: Our project demonstrate that implementation of the
assessment tool along with training and education can improve the
foot assessment among diabetic inpatient .
P334
Video training in diabetic foot examination:
from initial conception to wider
dissemination
F Medici and M Soliman
Department of Metabolic Medicine, Homerton University Hospital, London,
UK
Introduction: The need for screening large number of individuals
for diabetes foot problems poses challenges of manpower and
training. Screening needs to be performed by a variety of
healthcare professionals. Face-to-face training is key but further
educational adjuncts may be helpful.
Aim: to establish the need for a resource on diabetic foot
examination, produce a training video, ensure access, assess its
impact, further develop the resource and guarantee wider dissem-
ination.
Methods: Consultation about training needs, production of a
video on diabetic foot examination meeting the national standards
(Diabetes UK 2011 and TRIEPodD-UK 2012). Staff questionnaires
to evaluate the initiative and national diabetes inpatients audit
(NaDIA) to assess its impact on clinical practice. Technical
upgrade, availability of the resource and dissemination using IT
platforms.
Results: Feedback from the diabetes team highlighted the need for
additional targeted training available long-term. An initial version
of the video was disseminated through meetings followed by
discussion. Evaluation questionnaires were completed before and
after its introduction, showing a significant improvement in skills
and confidence. NaDIA showed a huge improvement in inpatients
screening between 2015 and 2016. We obtained funding from the
London School of Medicine for an upgrade. The second version of
the video is available on the Homerton Hospital intranet and
youtube channel as well as the Synapse website, the NHS Health
Education England communications network supporting postgrad-
uate training in London.
Conclusions: This is the first training video widely available in the
UK and meeting defined standards. It is a versatile, real-time, cost-
effective and long-term adjunct to face-to-face training.
P335
Glycaemic variability as measured by the
magnitude of change of visit to visit HbA1c
concentrations over the five years prior to
presentation, is significantly associated
with rate of wound healing in the diabetic
foot
E Li Ping Wah-Pun Sin1, J Cheng1, F Li1, A Yue1, C Gooday1,2,
I Nunney1 and K Dhatariya1,2
1Norwich Medical School, University of East Anglia, Norwich, UK, 2Elsie
Bertram Diabetes Centre, Norfolk and Norwich University Hospitals NHS
Foundation Trust, Norwich, UK
Background: Recent work has suggested that glycaemic variabil-
ity – the visit-to-visit variation in HbA1c – plays a role in the
development of micro and macrovascular disease in patients with
diabetes. However, whether HbA1c variability is a factor deter-
mining wound healing in diabetes related foot ulcers remains
unknown.
Aim: To investigate whether HbA1c variability is associated with
healing time in patients presenting to our multidisciplinary
specialist foot clinic.
Method: A retrospective analysis of patients attending between
July 2013 and March 2015, with at least three HbA1c measure-
ments five years prior first appointment and with more than two
follow-up reviews up to one year of first appointment. HbA1c
variation was measured by magnitude of Standard Deviation.
Results: 629 foot ulcers were referred to the clinic between July
2013 and March 2015. 328 cases were excluded. Of the remaining
301, 181 patients had their number of days to healing recorded.
The overall geometric mean days to heal was 91.1 days (SD 80.8 to
102.7). In the low HbA1c variability group the geometric mean
days to heal was 72.1 days (58.3 to 89.1) and in the high Hb1Ac
variability group the geometric mean days to heal was 106.5 days
(89.4 to 126.9), (p < 0.05).
Discussion: Our novel data has shown that wound healing of a
foot ulcer is significantly associated with HbA1c variability, with
lower variability associated with shorter time to heal. These data
confirm the importance of maintaining steady glycaemic control,
but also emphasise that large variations in HbA1c over time lead to
longer healing times.
P336
Neuropathy is more common than
peripheral vascular disease or deformity as
a risk factor for diabetic foot in urban Indian
population
S Rajbhandari1,2
1Diabetes Department, Lancashire Teaching Hospital, Chorley, UK,
2Screening Team, Diabetacare, Bangalore, India
Aim: Foot screening is uncommon in India due to lack of
awareness. We developed a mobile screening van, which can be
driven away for screening of chronic complications of diabetes. We
wanted to analyse various risk factors of foot ulceration in this
population.
Method: 12 mobile vans were used for screening at various
primary care practices in India. They were equipped with retinal
camera, point of care pathology test, ECG and detailed foot
assessment tools. Screening was performed by trained nurses using
standard protocols.
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Results: 5,000 subjects were screened in urban and sub-urban
India and available foot data on 969 were analysed. Mean age was
54.1 (11.5) years. 55 (5.7%) subjects needed active treatment on
the spot for active ulcers or painful corn. 637 (72.6%) were not
wearing appropriate footwear. Neuropathy in the form of absent
monofilament sensation was present in 149 (15.4%) subjects. 34
had absent Dorsalis Pedis and 35 had absent Posterior Tibial
pulses. 34 had a history of foot ulcers and 16 had previous
amputations. Foot deformity was present in 38 subjects. Fissures
were present in 452 (46.6%) and 434 (44.8%) had symptoms of
painful neuropathy.
Discussion: High risk foot is present in 15% subjects due to
neuropathy but peripheral vascular disease was rare. This may be
due to younger age of this population. Foot deformity was less
common in this population possibly due to use of open shoes and
the use of protective footwear was lacking. There is a need to
increase awareness of diabetic foot problem in India.
Acknowledgement: Screening Team
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The use of thermal imaging in the follow-up
of healed diabetic foot ulcers
NL Petrova1, W Tang1, A MacDonald2, C Lomas3, S Ainarkar4,
J Bevans4, J Allen2, P Plassmann5, G Machin6 and
ME Edmonds1
1Diabetic Foot Clinic, King’s College Hospital NHS Foundation Trust, London,
UK, 2Microvascular Diagnostics, Newcastle upon Tyne Hospitals Trust,
Newcastle, UK, 3Podiatry Department, Newcastle upon Tyne Hospitals Trust,
Newcastle, UK, 4Community Podiatry Department, Pennine Acute Hospitals
Trust, Manchester, UK, 5Photometrix Imaging Ltd, Pontypridd, UK,
6Temperature and Humidity, National Physical Laboratory, London, UK
Aims: The aim was to use a novel thermal imaging system to
determine bilateral skin temperatures at sites of previously healed
foot ulcers in diabetic patients. Previous studies in high-risk
patients with infrared spot thermometry have shown that areas
with foot temperature 2.2°C or greater than the corresponding
contralateral site are at risk of an ulcer.
Methods: In this multi-centre trial (NCT02579070) we studied
47 patients (37 males; age 61  11.6 years [mean  SD]; 14 type
1 and 33 Type 2 diabetes; mean duration of diabetes 21  13.8
years) with a past history of ≥1 foot ulcer and intact feet for ≥3
months. Skin temperatures at the sites of healed foot ulcers and
their corresponding contralateral sites were measured and the
temperature difference (DT) was calculated.
Results: Eight patients had a history of bilateral symmetrical
ulcers and DT was not applicable. Fifty-eight healed ulcer sites in
39 patients were analysed. Twenty-eight ulcer sites were warmer
than the contralateral sites (DT range 0°C to 2.1°C). Twenty two
ulcer sites were cooler than the contralateral sites (DT range -0.1°C
to -2.1°C at 20 sites and DT below -2.2°C at 2 sites). However, at
eight healed ulcer sites, DT was greater than 2.2°C (DT range 2.5°C
to 8.6°C) and these sites were classified as hot spots on the thermal
images. These hot spots were offloaded as per local standards and
none had ulcerated at the next clinic visit (2-4 weeks).
Conclusions: This study shows the potential role of thermal
imaging in the assessment and prevention of diabetic foot ulcers.
Acknowledgement: The views expressed are those of the authors
and not necessarily those of the NHS, the NIHR or the Department
of Health.
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Age at amputation is strongly related to
mortality during ten years follow up
B Pac Soo1, U Ranasinghe2, R Jayatilake2, A Egun3 and
S Rajbhandari2
1Manchester Medical School, Preston Hospital, Preston, UK, 2Diabetes
Department, Lancashire Teaching Hospital, Chorley, UK, 3Vascular Surgery,
Lancashire Teaching Hospital, Preston, UK
Objectives: NICE literature review suggests that in diabetes
patients, up to 70% of people die within five years of having an
amputation. We wanted to study ten years survival after first
recorded lower limb amputation in our cohort.
Method: This was a retrospective study on 233 patients (159
males) who underwent amputation between 1997 and July 2006.
List was obtained from discharge summary and theatre record. 63
subjects underwent further amputation but were grouped as their
first amputation level into major (above ankle) or minor (below
ankle). Electronic database was examined in August 2016 to know
the date of their death.
Results: During follow up one year survival was 64%, three years
50%, five years 40%, seven years 34% and 10 years 28%. People
who died by 10 years were older (70.2 11.5 vs 62.4 12.2 years:
P < 0.0001) and had serum album level below normal at presen-
tation (p < 0.05). There was no difference in 10 year mortality
between gender, presence of anaemia, cholesterol level and HbA1c
level (p > 0.05) at presentation. There was no difference in 10 year
mortality with amputation level.
Discussion: Mortality was highest within 12 months, which could
be due to existing co-morbidities. It was stable after five years. Old
age was related to death in our study but level of amputation was
not, which could be due to 63 subjects who underwent further
amputation but were grouped as their first recorded amputation.
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Five year mortality following diabetic
amputation has not changed over 14 years
B Pac Soo1, U Ranasinghe2, R Jayatilake2, A Egun3 and
S Rajbhandari2
1Manchester Medical School, Preston Hospital, UK, 2Diabetes, Lancashire
Teaching Hospital, Chorley, UK, 3Vascular Surgery, Lancashire Teaching
Hospital, Preston, UK
Objectives: There is higher five year mortality following diabetes
related amputations. We wanted to study if this has changed over
the last 14 years in our cohort.
Method: This was a retrospective study on 356 patients who
underwent amputation between 1997 and 2010. List was obtained
from discharge summary and theatre record. Subjects who under-
went amputation between 1997 and 2003 were ‘Early’ cohort and
those between 2004 and 2010 were ‘Late’ cohort. Amputations
were grouped at their first surgery into major (above ankle) or
minor (below ankle). Electronic database was examined in 2016 to
know the date of their death.
Results: There was no difference in the mean number of total
amputations performed annually between early and late cohort (25
 8.8 vs 25.9  4.9; p > 0.05), however there was a significant
reduction in major amputations performed annually (18.4  3.9 vs
12.9  3.2; p = 0.01) and a trend for a rise in minor amputations
(6.6  6.3 vs 13.0  5.1; p = 0.07) between these cohorts. Five
year mortality was 59% which was significantly higher in major
amputation group than minor (63.9% vs 51.1%; p = 0.02). There
was no difference between ‘Early’ and ‘Late’ cohorts in five year
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total mortality (60.1% vs 57.4%; p > 0.05), major amputation
mortality (63.2% vs 64.0; p > 0.05) or minor amputation mortal-
ity (43.9% vs 52.8%; p > 0.05).
Discussion: There has been no change in total mortality with time
in subjects with diabetes who needs lower limb amputations.
P340
Use of a bedside foot assessment chart to
increase uptake of foot checks for
inpatients with diabetes
M Phylactou1, L Fermor1, L Wang1, E Rooney2, K Baynes1,
M David1 and SR Mehta1
1Diabetes and Endocrinology, Ealing Hospital, London North West Healthcare
NHS Trust, London, UK, 2Podiatry, Ealing Hospital, London North West
Healthcare NHS Trust, London, UK
Objectives: Inpatients with diabetes have a 2-fold increased risk of
hospital acquired pressure ulcers of grade 2 or above. The question is
can this excess burden be reduced by specifically targeting peoplewith
diabetes forpressureulcer prevention.NICEguidance suggests thatall
inpatientswithdiabetes shouldhave their feet checkedand their riskof
ulceration stratified within 24h of hospital admission. Data from the
National Diabetes Inpatient Audit (NaDIA) in 2013 showed that at
our institution only 20% of inpatients with diabetes received a foot
risk assessment within such a timeframe.
Methods: We introduced a simple bedside foot assessment chart
prior to the NaDIA in 2015 and provided teaching sessions to
healthcare assistants, diabetes link nurses and doctors to encourage
its use.
Results: The percentage of inpatients with diabetes receiving a foot
risk assessment within 24h of admission improved from 20.4% to
58.3%, while the percentage that received a foot risk assessment
during their inpatient stay rose from26.5%to72.9%.The percentage
of patients admitted with active diabetic foot disease seen by the
multidisciplinary diabetic foot care team (MDFT) within 24h
improved from 77.8% to 100%. Preliminary data from this year’s
NaDIA show that we have maintained these improvements.
Conclusions: Introduction of a bedside foot assessment chart has
led to a significant improvement in the proportion of inpatients
with diabetes receiving a timely foot risk assessment, and has
ensured that all patients admitted with active diabetic foot disease
were seen by the MDFT within 24h.
P341
Bacterial profile and antibiotic resistance
patterns in hospitalised patients with
diabetic foot infection
AB Manas, R Ahluwalia, S Taori, ME Edmonds and P Vas
Diabetic Foot Clinic, King’s College Hospital, London, UK
Aims: Studies on microbiological profiles of the diabetic foot have
been based on a mix of outpatient and hospitalised-patient cohorts.
We aimed to determine the bacterial profile and antibiotic
sensitivity patterns specifically in those admitted to hospital with
severe diabetic foot infection.
Methods: Retrospective review of 59 consecutive hospital admis-
sions (Age 63  9 years, 85% T2DM, HbA1c 8.9  2.1%) with a
Texas Grade 3 ulceration and clinico-radiological evidence of
osteomyelitis over a 9 month period. Deep swabs were taken at
admission and bone samples, during debridement surgery. Mul-
tidrug resistant organisms (MDRO) were defined as those resistant
to most available antimicrobial agents.
Results: A total of 118 specimens were included. Of the 144
organisms isolated, 43% were gram-positive and 44% gram-
negative. Polymicrobial infection was found in 27.97% of speci-
mens. Multidrug resistant organisms (MDRO) were encountered
in 16/59 (27.1%) of patients and included ESBL producers (25%),
MRSA (18.8%), VRE (25%), Morganella sp. (12.5%) Pseu-
domonas (7%) and Stenotrophomona sp. (11.8%) Carbapenem
resistance (CRO) was noted in 7% of isolates. Worryingly,
presence of MDRO did not correlate with duration of a ulceration
(p = 0.937) or previous antibiotic therapy (p = 0.94).
Conclusions: The present study confirmed the high prevalence of
multidrug-resistant pathogens in diabetic foot ulceration and con-
comitant osteomyelitis. The emergence of carbapenem resistance
organisms is likely tobemajor future challenge.The problemrequires
a multi-focal approach, including providing education to both
clinicians and patients, developing robust antimicrobial stewardship
programmes and using new diagnostic and therapeutic technologies
P342
Audit on management and outcome of
patients presenting with acute Charcot
Neuropathy of foot and ankle to the Leeds
Diabetes Limb Salvage Service
A Santhakumar1, H Meally2, S Kummaraganti1 and
JH Bodansky1
1Leeds Diabetes and Endocrinology, Leeds Teaching Hospitals, Leeds, UK,
2Department of Podiatry, Leeds Teaching Hospitals, Leeds, UK
Aims: To look at the management and outcome of patients
presenting to the Leeds Diabetes Limb Salvage service with acute
Charcot Neuropathy (CN)
Methods: All patients presenting with acute CN in 2014–2015
were identified from our diabetes database. Electronic records were
examined to determine demographic details, time interval (TI)
between onset of symptoms to offloading, offloading devices used
and resolution times. We compared our data with that of National
Charcot Foot Audit 2012 (CDUK)
Results: A total of 19 patients were identified M:F 14:5 Type 1:
Type 2 diabetes 11:7.
Figures below are expressed as average (range)
Age 64.5 years (32-83) Duration of diabetes 18 (6-44) years
HbA1c 72mmol/mol (34-158)
15/19 patients had mid foot involvement
At outset 15 patients were offloaded with a removable device, 4
with irremovable cast (TCC) 18/19 patient achieved resolution of
their CN .One patient died
(excluded from further analysis) .
CDUK resolution times for patients with non removable and
removable devices were 9 and 12 months respectively compared to
three and nine months for TCC and removable devices respectively
in our series.
Time between onset of symptoms and presenting to the diabetes
limb salvage clinic was 10 weeks (0.14-96)
Median resolution time for presentation < / = 2 weeks and > 2
weeks of symptoms was 3 and 5.5 months respectively
Conclusion: 1. Offloading within 2 weeks of symptoms and
exclusive non removable casts use were associated with shorter
resolution times
2. Resolution times in our series were shorter than that reported in
CDUK
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Real time data on use of SINBAD grading in
stratification of high risk neuro-ischemic
diabetic foot disease and severity score in
predicting amputations in a University
Hospital
HA Bajwa, S Dar, S Nawaz, G Deogon, R Rao and N Murthy
Diabetes and Endocrinology, University Hospital Coventry, Coventry, UK
Background and aim: NICE recommends use of a standardised
system to document the severity of diabetic foot ulcer, such as the
SINBAD. We audited the clinical effectiveness of SINBAD in our
diabetic foot clinic, particularly the severity score in predicting
amputations.
Methods: We retrospectively looked at 100 patients who
attended the diabetic foot clinic from June 2015 to August 2015.
After exclusion of patients with painful neuropathy and charcot’s
foot, we analysed data of 71 patients having diabetic foot ulcer. All
patients had scoring as per SINBAD grading.
Results: The data of 71 patients was analysed, 53 male patients,
average age of 63.4 years and average HbA1c of 67.9mmol/mol. In
our cohort, 38% had SINBAD score ≤2, while 62% had score of
≥3. The rate of osteomyelitis was 21% (n15) in total with 87%
(n13) having SINBAD score of ≥3.
The amputation rate in our cohort was observed at 15.5%(n11)
and 4.2%(n3) for minor (below ankle) and major (above ankle)
amputations respectively. 85.7% (n12) of amputations were
performed in patients having SINBAD score ≥3, and all major
amputations were seen with SINBAD score of ≥3.
Conclusion: A SINBAD score of ≥3 was associated with increased
incidence of osteomyelitis and amputations. A SINBAD score ≥3
strongly predicts future risk of amputation and hence these patients
need to be managed with swift vascular assessment and interven-
tion. At our centre, we closely liaise with vascular surgeons and
discuss management of high risk patients in complex foot MDT.
P344
Outcomes of patients with diabetes and
foot ulcers cared for in a multidisciplinary
foot clinic including focus on cardiovascular
risk factors
J Lam, G Argentesi, J Buchanan, J Preece, A Wilson and
M Rossi
Department of Diabetic Medicine, The Whittington Hospital NHS Trust,
London, UK
Aims: Foot ulcers are associated with increased morbidity and
mortality in patients with diabetes. In this study, we assessed the
outcomes of patients referred to a multidisciplinary diabetes foot
clinic at an inner city hospital in London, UK. Care provided
included using a cardiovascular risk factor screening process
during each visit, and a strong emphasis on reducing these risk
factors.
Methods: We performed a retrospective analysis of patients with
diabetes seen in a multidisciplinary diabetes foot clinic between
2005 and 2010. 5 year outcomes on re-ulceration, osteomyelitis,
amputation and mortality rates were collected.
Results: 120 patients were seen in the clinic during the 5 year
period (81% were male, mean age at first appointment  SD was
64  13, 89% had Type 2 diabetes). 25% of patients had evidence
of osteomyelitis at the time of their first review. At least one
amputation was undertaken in 18% of patients (15% minor and
3% major), while 3% required two or more amputations. Re-
ulceration was seen in 38% of patients, 15% developed two or
more new ulcers, and 8% developed at least three new ulcers
during follow-up. 5 year mortality rate was 37%.
Summary: Multidisciplinary care has been shown to improve
outcomes in patients with diabetic foot ulcers, although mortality
and amputation rates remain high nationally. The 5 year mortality,
major and minor amputation rate reported in our multidisciplinary
clinic compares favourably with reported averages suggesting focus
on cardiovascular risk factors may improve outcomes.
P345
Novel method of auto-photo elicitation and
qualitative interviews in people with
diabetes and active Charcot foot
demonstrate the severe impact of diagnosis
of a Charcot foot and its long-term
management with total contact casting on
patient’s perceived quality of life and sense
of wellbeing
J Lucas1, S Otter2, C Clarke2, A Bone3, N Petrova1 and
M Edmonds1
1Diabetic Foot Clinic, King’s College Hospital, London, UK, 2Health
Professions, University of Brighton, Eastbourne, UK, 3Biomolecular Sciences,
University of Brighton, Brighton, UK
Aim: The aim of this research was to enhance the understanding
of the lived experience of active Charcot foot in people with
diabetes.
Method: We studied prospectively patients recently diagnosed
with an active Charcot foot. We applied a novel method of auto-
photo elicitation and qualitative interviews. Participants were
asked to bring in 3-5 of their own photographs to demonstrate
how the diagnosis and management of active Charcot foot had
affected their lives. These photographs were used as the basis of a
discussion in a semi-structured interview and evaluated using
interpretive phenomenological analysis.
Results/Discussion: We interviewed 8 patients with diabetes and
active Charcot foot (6 males and 2 females; age range 46-73 years;
2 with Type 1 and 6 with Type 2 diabetes). All patients were
treated with total contact casting. Patients identified several areas
of concern including non-recognition of symptoms and misdiag-
nosis, lack of available information, the challenges of acceptance,
effects on diabetes, depression and suicidal thoughts, isolation, loss
of meaningful activity and employment, changing sense of self,
effects on relationships, and fear of the future. All patients saw
being diagnosed with a Charcot foot as a marker of overall decline
in health and wellbeing.
Conclusion: This is the first study that explored the patient’s
perspective of the lived experience of active Charcot foot and its
treatment. It demonstrated that both the diagnosis of Charcot foot
and its long-term management with total contact casting, had an
immediate and severe impact on patient’s perceived quality of life
and sense of wellbeing.
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P346
Early results from a technology-enabled
integrated diabetes foot care service
F Game1, D Bunting2, A Patel3 and C Hart4
1Diabetes and Endocrinology, Derby Teaching Hospitals NHS Foundation
Trust, Derby, UK, 2Podiatry, Derbyshire Community Health Services NHS
Foundation Trust, Derby, UK, 3Entec Health Ltd, Esher, UK, 4East Midlands
Academic Health Science Network, Notttingham, UK
Aim: We describe our experience with developing and delivering
an integrated diabetes foot service, using a new web enabled digital
imaging and 3D measurement technology.
Method: Five Silhouette® digital wound cameras have been
placed in relevant clinical areas (2 in the acute Trust, 3 community
health centres) across two CCGs. All patients registered with the
Trust specialist MDT foot clinic have digital images and clinical
notes uploaded at every appointment. Data on ulcer size and ulcer
healing progress is also generated. Once stable, patients are seen in
community clinics by specialist podiatrists with distant monitoring
support from consultants using the tele-capability of the system.
Rapid escalation of patients back to the MDT, if necessary, is
facilitated by the availability of data and reports across all settings
and integration of the system with the Trust electronic medical
record.
Results: 18 members of staff are now fully trained in the use of
the system. In the first few weeks of use 35 patients were seen in
community settings rather than the acute Trust with no deterio-
ration in their condition. Data is being collected for health
economic analysis, although initial health economic modeling
forecasts significant reduction in costs to provide foot care to this
cohort of patients.
Conclusion: This new system enables accurate analysis of wound
healing and sharing of images and data across care settings.
Remote monitoring of wounds with rapid escalation and de-
escalation of care means that patients can be seen closer to home
without any deterioration in their condition.
P347
Tangential hydrosurgical debridement: a
potential role in major amputation
avoidance for people with diabetes
E Ricci1, D Knowles1, L Wright1 and R Nayar2
1Podiatry, City Hospitals Sunderland NHS Foundation Trust, Sunderland, UK,
2Diabetes, City Hospitals Sunderland NHS Foundation Trust, Sunderland, UK
Introduction: Slow or non-healing wounds in people with
diabetes contain dead, devitalised tissue and slough which is
associated with bacterial overgrowth. Several debridement meth-
ods exist, management choice is dependent upon individual clinical
circumstances and patient preference. We evaluated tangential
hydrosurgical debridement (Versajet) as a method of final debride-
ment in a high risk group.
Aims: Evaluate the utility and place in clinical practice of this
method in a high risk group who had
(a) Undergone significant forefoot surgical debridement for an
active infected diabetic foot ulcer.
(b) The resultant wound was poorly responsive to medical
management, hence.
(c) Been formally listed for major amputation.
Results: Eight consecutive patients with diabetes were offered
Versajet treatment. Seven with Type 2 diabetes, three patients were
on renal dialysis. 5 male, 3 female; average age 61 years and
average duration of diabetes 17 yrs. Average HbA1c for the group
61mmol/mol (range 37 – 78mmol/mol). Wound aetiology 3
ischaemic and 5 neuropathic. Major amputation was avoided in
6 of the 8 patients. Both patient in which the therapy failed were on
dialysis. One patient who underwent a below knee amputation
died within three months of surgery. Debridement occurred in the
outpatient clinic for seven patients and for one treatment occurred
in theatre. For three patients two episodes of hydrosurgical
debridement was necessary.
Conclusion: Our small case series suggest that this method of
rapid debridement can offer a potentially effective alternative to
wound management in high risk patients. For those patient on
renal dialysis the benefit is difficult to predict.
P348
Site-specific relationship between plantar
ulcer sites and elevated peak plantar
pressures
CA Abbott1, KE Chatwin1, KM John1, S Pabbineedi1,
AJM Boulton2, FL Bowling2,3,4 and ND Reeves1
1School of Healthcare Science, Manchester Metropolitan University,
Manchester, UK, 2Faculty of Biology, Medicine and Health, University of
Manchester, Manchester, UK, 3Department of Diabetic Medicine,
Manchester Royal Infirmary, Manchester, UK, 4Department of Vascular
Surgery, Manchester Royal Infirmary, Manchester, UK
Aims: The effect of elevated plantar pressures on foot ulcer risk
has been reported only across the foot as a whole and not in
relation to specific ulceration sites. The great toe is one of the most
frequently ulcerated sites on the diabetic foot. We aimed to
investigate peak plantar pressure at the great toe in diabetic
patients with a previous great toe plantar ulceration and in patients
with equally ‘high-risk’ feet, but with a previous ulceration at
another plantar location.
Methods: Great toe peak plantar pressures were quantified
during gait using PressureStatTM in three age-matched groups:
diabetic patients with neuropathy and plantar ulcer history at the
great toe (DPN-UGT; n = 9); diabetic patients with neuropathy
and ulcer history at other plantar sites (DPN-U; n = 6); matched
controls without diabetes (C; n = 12).
Results: Plantar pressures at the great toe were significantly higher
in DPN-UGT (4.58  1.81kg/cm2) compared to both DPN-U
(2.36  1.09kg/cm2; p = 0.001) and C (2.42  0.63kg/cm2;
p = 0.009). There were no differences in plantar pressures at the
great toe site between DPN-U and C (p = 0.650).
Conclusion: We demonstrate a site-specific relationship between
previous ulceration and very high plantar pressures. ‘High risk’
diabetic patients with great toe ulcer history have highest great toe
peak plantar pressures. Conversely, ‘high risk’ patients with ulcer
history at sites other than the great toe have ‘normal’ great toe
pressures, similar to controls. Specific plantar sites, identified in
clinic with previous ulceration and elevated peak pressures, can be
recommended to receive site-targeted offloading to protect against
their re-ulceration.
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Forefoot transcutaneous oxygen (TcpO2)
Index is a more sensitive marker of
peripheral vascular disease than ABPI or an
isolated forefoot TcpO2
CA Manu, D Walton, J Casy, M Bates, PR Vas and ME Edmonds
Diabetes Foot, King’s College Hospital, London, UK
Background: Presence of peripheral vascular disease (PVD) in
diabetes, which also worsens with ageing, has a significant negative
impact on diabetes foot outcomes, but it is often diagnosed late.
Aim: To investigate the possible benefit of forefoot transcutaneous
oxygen (TcpO2) expressed as an index of forearm TcpO2 in
enhancing detection of early PVD in patients with diabetes.
Method: Measurements were taken from the forefoot and fore-
arm for ABPI, TBPI, forefoot TcpO2, forearm TcpO2, and TcpO2
Index (forefoot TcpO2 divided by forearm TcpO2). We compared
measurements in patients with Type 2 diabetes vs participants
without diabetes, and sub-analysed the impact of ageing and its
correlation with non-invasive diagnostic parameters of PVD.
Results: Total of 68 participants, 78% with diabetes, and 22%
without diabetes. Mean age 63  12 vs 46  11 years [p = 0.001].
Therewasno significantdifferencebetween theirmeanABPI; 1.2  0.4
vs 1.14  0.31 [p = 0.104]. Mean forefoot TcpO2 and TcpO2 Index
were lower inparticipantswithdiabetes,47  15mmHgvs64  7mm
Hg [p = 0.001] and 0.78  0.24 vs 0.91  0.09 [p = 0.003] respec-
tively, but participants with diabetes had significantly negative corre-
lation of forefoot TcpO2 with ageing r = -0.306, which becomes
strongerwhen expressed as an indexof the forearmTcpO2 (r = -0.469).
Conclusion: ABPI does not identify early PVD in participants
with diabetes. TcpO2 Index is a more sensitive marker than an
isolated forefoot TcpO2 in detecting PVD. Thus this ought to be
considered as an alternate means of an early and objective non-
invasive diagnostic parameter for PVD to identify patients for
further investigations or monitoring.
P350
Diabetes care in an orthopaedic led foot
clinic
R Maahi, AM Ahmad, A Khan, Z Bhikha, T Khokhar,
PJ Weston, D Sharma, TS Purewal, R Zaidi and D Kalathil
Diabetes and Endocrinology, Royal Liverpool and Broadgreen University
Hospitals NHS Trust, Liverpool, UK
Aim: The NHS spends several million pounds on 7,000 diabetes
related amputations a year; 80% of these are preventable.
Prevention requires tight glycaemic control and optimisation of
contributory risk factors. We aimed to evaluate the diabetes care
received by patients attending an orthopaedic-led foot clinic for
management of diabetic foot disease.
Methodology: Data was collected using a standardised proforma
for 38 patients attending clinic over a 7 week period. Microsoft
Excel was used for analysis.
Results: 29 patients (76.3%) had diabetes (17.2%Type 1 diabetes,
82.8% Type 2 diabetes) with mean HbA1c of 77.2mmol/mol.
13.8% had good glycaemic control (HbA1c < 53mmol/mol).
79.3% required insulin to manage diabetes.
100% had previous foot disease and 69.0% had a previous
amputation. 89.7% had peripheral neuropathy and 34.5% had
peripheral vascular disease. Other diabetes related complications
present were hypertension (75.9%), ischaemic heart disease
(31.0%), cerebrovascular disease (20.7%), retinopathy (62.1%),
and chronic kidney disease (34.5%). 17.2% were current smokers.
In the preceding 12 months 82.8% had HbA1c measured and
44.8% had lipid profile checked. 65.5% were on a statin. Only
31.0% had their diabetes managed by a diabetes specialist.
Conclusion: Patients with diabetic foot disease have poor gly-
caemic control, modifiable risk factors and multiple complications,
making their care needs complex. Their diabetes management does
not seem to receive the attention it merits. We believe these patients
should be looked after in a multidisciplinary foot clinic as
recommended by NICE if we wish to succeed in preventing
recurrent foot disease.
P351
The need for more open access to specialist
diabetes foot care services: supported by
high appointment complexity score for new
self-referred patients
D Walton, M Bates, CA Manu, M Simmgen, PR Vas and
ME Edmonds
Diabetic Foot Clinic, King’s College Hospital, London, UK
Background: Patients with diabetes foot problems ought to have
rapid access to foot care teams. Our clinic offers an open access
policy, allowing patients to self-present directly to our specialist
foot care service.
Aim: To evaluate the complexity of self-referred patient visits
compared to other sources of new-referrals.
Method: New patient visits were reviewed over a six month
period. A “visit complexity score” (VCS) is calculated to reflect all
investigations and interventions carried out during the consulta-
tion. Each activity is given a point score between 0 and 6
depending on its complexity (e.g. 0 for foot checks without
procedures, 1 for debridement of callus, 4 for drainage of pus, 6 for
minor amputation). A sum of all activity points equates to the VCS.
Referral source were divided into four groups: Self-referred,
Community Podiatrist, Secondary Care or GP. The VCS and
patient characteristics were compared between groups.
Results: There were 219 new-patient referrals. Of those with
complete data, 4% were self-referred with a significantly higher
mean VCS of 6.2  2.4points compared to the overall mean
4.1  2.3points [p = 0.025]. The remaining referrals were 8%
community podiatry, 40% secondary care and 47% from GPs all
demonstrated a lower mean VCS when compared to the self-
referred groups calculated as 4.4  2.1, 4.4  2.5 [p = 0.040] and
3.9  2.2points [p = 0.013] respectively. No significant difference
was identified between mean ages or HbA1c.
Conclusion: Self-referred patients had higher visit complexity
scores, thus their decision to self-present was well justified. More
of such open access appointments ought to be offered to facilitate
rapid access to specialist diabetes foot care.
P352
High prevalence of cognitive and non-
depressive psychiatric comorbidities in
those admitted to hospital with diabetic
foot disease
SA Arshad1, JT Tremlett1, CM Manu1, ME Edmonds1, KI Ismail1
and PR Vas2
1King’s Diabetic Foot Clinic, King’s College Hospital London, London, UK,
2Department of Diabetes and Diabetes Psychology, King’s College Hospital
London, London, UK
Aim: The high prevalence of depression is well recognised in
diabetic foot disease (DFD). However, the prevalence and impact
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of significant cognitive and non-depressive psychiatric comorbidi-
ties (C/NDPC) in DFD has not been well documented. We aimed to
explore this in a cohort admitted to hospital for the management of
DFD.
Methods: Analysis of 90 individuals, prospectively collated over
five months, hospitalised with DFD at a single centre. C/NDPC
was considered present if there was a pre-existing diagnosis of a
cognitive or an ICD-10 Classification of Mental and Behavioural
Disorder/s apart from depression (F32-38). Differences in charac-
teristics between participants were tested using unpaired t -test and
odds ratio calculated where necessary.
Results: Overall, the group was predominately male (75%) with
an average age of 61  13 years and HbA1c of 8.8  3.4%. 37%
(33/90) had C/NDPC of which 30% (10/33) had dementia. Those
with C/NDPC were younger (59 years vs 62 years (p = ns), had
higher HbA1c 9.3% vs 8.2% (p = 0.05) and presented more often
through the emergency department (61% vs 43%, p = 0.11).
There were 3 major amputations in the C/NDPC group, while
there were none in those without. Not unsurprisingly, those with
C/NDPC had a longer length of stay (48  59 vs 33  12 days,
p = 0.02), required greater therapy input (178min/week vs
110min/week, p < 0.05) and were twice as likely (odds ratio
1.98 p = 0.04) to have housing/placement issues.
Conclusions: We establish a high prevalence of C/NDPC amongst
those hospitalised with DFD. These patients a present significant
clinical challenge and demonstate inferior outcomes. This under-
scores the need for continued multidisciplinary involvement
including strong psychosocial support.
P353
Still room for improvement in the
management of diabetes foot ulceration:
learning from a retrospective study of 100
cases selected at random from caseloads in
Northern Ireland
J Shaw1,2 and LM Paine1
1Podiatry, Belfast Health and Social Care Trust, Belfast, UK, 2Diabetes UK
Clinical Champion, Diabetes UK, London, UK
Aims: To optimise care and inform service planning we set out to
determine the number of people without diabetes, with diabetes
and with diabetes foot ulceration (DFU) on Podiatry caseloads.
Management of DFUs was mapped against national standards.
Methods: A descriptive retrospective cohort comprised of those
with and without diabetes and those with DFUs was identified in
2013–2014. Subjects (n = 100 including pilot study, n = 25)
were randomised electronically from caseload lists. Data were
collected on diabetes status, assessment, risk assignment, DFU
classification, healing time, ulcer prevention and amputation
rates. Practice was assessed against NICE guidelines and Putting
Feet First.
Results: The Podiatry caseload was 136,808, including 53,590
people with diabetes and 2,468 had a DFU (4.6%). Average
diabetes duration in DFU patients was 17 years with an average
HbA1c of 70.9mmol/mol. Neuropathy and foot pulse assessment
was completed in 60% and 64% people respectively. Foot risk was
classified and assigned in 72% and 74% had a review date
appropriate to DFU risk. All had management plans documented
and 54% had all elements of a DFU classification system
completed. Footwear assessment was completed in 84%. At 12
and 24 weeks 57% and 74% of DFUs had healed and 41%
remained ulcer free 12 months from healing. Thirteen patients had
an amputation and seven were deceased at 24 weeks.
Conclusion: We recommend that diabetes foot assessments, risk
assessment, risk assignment and review be standardised and
improved regionally. A regional DFU classification system has
been agreed and will become embedded in Podiatry practice.
P354
Role of admission time deep swab
specimens in the managment of acute
severe diabetic foot osteomyelitis
AB Manas, R Ahluwalia, S Taori, M Edmonds and P Vas
Diabetic Foot Clinic, King’s College Hospital, London, UK
Aim: Our study aimed to evaluate if deep swab cultures taken at
time-point of a hospital admission with a severe diabetic foot
infection could reliably identify pathogens compared to cultured
bone specimens.
Method: Retrospective review of consecutive hospital admissions
with a severely infected diabetic foot, Texas Grade 3 ulceration
and clinico-radiological evidence of osteomyelitis over a 9 month
period. A deep swab (DWS) was taken at time of admission. Bone
sampling was undertaken during surgery (SBS). The number of
positive growths per individual per sampling technique was then
determined and data is represented as such.
Results: A total of 59 subjects (average 60.79  13.61 years,
75% male, 85% Type 2 diabetes, HbA1c 8.9%  2.15) met the
inclusion criteria. 49% of wounds were chronic. 25% of patients
had been on long-term antibiotic treatment. Of the 59 patients, 42/
59 (73%) of DWS and 50/59 (85%) of SBS were positive. Mean
number of organisms isolated by DWS was significantly lower than
with SBS (1.23  0.57 vs 1.68  0.79 individual, p = 0.000). On
comparing the cultures of DWS and SBS, the cultures were strictly
identical in 9 cases (15.25%) and at least one bone pathogen was
grown in the corresponding DWS in 11 cases (18.6%). There was
fair concordance in growth between the techniques (j = 0.344).
Staphylococcus aureus and MRSA showed the highest concordance
(j = 0.591 and j = 0.556, respectively).
Conclusion: This study confirms the poor reliability of the deep
swab technique in isolating all the pathogens causing osteomyelitis.
Early bone sampling should remain the mainstay of guiding
antibiotic therapy.
P355
Cost benefits of an integrated diabetic foot
service
M Sutton-Smith1, M Siddiqui1, T Gaytree1, M Kerr2 and
WM Kong1
1The Jeffrey Kelson Centre For Diabetes and Endocrinology, Central
Middlesex Hospital, London, UK, 2Insight Health Economics Ltd, Richmond,
Surrey, UK
Background: Brent has the lowest total diabetes amputation rate
in England. The Central Middlesex Hospital (CMH) acute
multidisciplinary foot has been credited with these results. Man-
agement focuses on targeted antibiotics and outpatient parenteral
antibiotic therapy (OPAT). However, comprehensive cost savings
from such a service remains to be established as previous studies
only consider limited costing factors.
Aim: To cost a year of care for high risk diabetic foot complica-
tions and the potential cost savings of a multidisciplinary OPAT
diabetic foot service.
Methods: Retrospective analysis of all patients with new high-
risk ulcers (SINBAD > 3) or acute Charcot foot presenting to the
CMH acute foot service between 1/04/2014–31/03/15 to 31st
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March. Sixteen costing factors including consumables (eg antibi-
otics, dressings, orthotics), health professional time (including
community staff), transport, imaging and line insertions. Cost
savings were calculated by comparing the marginal cost of the
service to estimated savings from averted amputations, relative to
comparable Clinical Commissioning Groups (CCGs).
Results: Seventy-eight consecutive patients: mean age 67.4 years
71 ulcers, 9 acute Charot’s (2 with ulcers). Median treatment time:
7.5 months. The marginal cost of the service was estimated at
£98,000/year. Savings from averted amputations, relative to the 10
most similar CCGs, are estimated at £155,000.
Discussion: This is the first detailed economic analysis of the costs
of a highly effective multidisciplinary OPAT foot service. There is a
national target of 50% fewer amputations by 2018. A detailed
understanding of the service requirements and their associated
costs is essential if this is to be achieved.
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P356
Impact on hypoglycaemia awareness of real
time continuous glucose monitoring and
intermittent continuous glucose data (I
HART CGM)
M Reddy, N Jugnee, E Spanudakis and N Oliver
Division of Diabetes, Imperial College, London, UK
Refer to Oral number A68
P357
A retrospective observational study of
patients with Type 1 diabetes with self-
reported severe hypoglycaemia reveals
high level of ambulance attendance but low
levels of therapy change and specialist
intervention
R Nayar1, B Field2,3, A Kilvert4, M Baxter5, J Hickey6,
M Cummings7 and S Bain8
1Sunderland Royal Hospital, City Hospitals Sunderland NHS Foundation Trust,
Sunderland, UK, 2East Surrey Hospital, Surrey & Sussex Healthcare NHS Trust,
Redhill, UK, 3Section of Investigative Medicine, Imperial College London,
London, UK, 4Northampton General Hospital, Northampton NHS Trust,
Northampton, UK, 5Sanofi, Guildford, UK, 6pH Associates, Marlow, UK,
7Queen Alexandra Hospital, Portsmouth NHS Trust, Portsmouth, UK,
8Singleton Hospital, Abertawe Bro Morgannwg University Health Board,
Swansea, UK
Aims: To describe the NHS resource utilisation associated with
self-reported severe hypoglycaemic events in patients with Type 1
diabetes.
Methods: An observational, multi-centre, retrospective study of
patients with Type 1 diabetes was conducted in 10 UK NHS
hospital diabetes clinics. Adult patients ( > 18 years) with Type 1
diabetes, insulin-treated for ≥2 years, experiencing ≥1 self-reported
severe hypoglycaemic event in the previous 24 months (observation
period) consented to retrospective data collection from medical
records.
Results: Eighty-five patients (59% male; mean age 57.0 [SD:14.8]
years) reported 140 episodes of severe hypoglycaemia during the
2year observation period; 74% were treated with basal-bolus
insulin analogue regimes and 92% had ≥1 comorbidity. Of 140
episodes, 59% involved ambulance call-out only, 8% involved
ambulance to Accident and Emergency (A&E), 4% involved
ambulance to A&E and inpatient admission, 7% involved A&E
only, 1% involved other hospital intervention and 21% required
no emergency intervention. Only 7% (n = 8/119) of HbA1c
measurements recorded closest prior to severe hypoglycaemic
events were < 50mmol/mol (6.7% DCCT-aligned). Patients
attended a median of 5 (range:0–58) diabetes clinic visits during
the 2 year observation period (13% severe hypoglycaemia-related).
A median of 0 (range:0–11) diabetes therapy changes/patient were
recorded during the observation period; hypoglycaemia was the
most commonly recorded reason for therapy changes (44% [52/
119 changes]).
Conclusions: We observed a high level of ambulance service
intervention but surprisingly low levels of hypoglycaemia follow-
up, therapy change and specialist intervention in patients self-
reporting severe hypoglycaemia. These findings may highlight
important issues in the diabetes care pathway.
P358
A pilot project assessing the feasibility of an
integrated hypoglycaemia pathway for
patients not conveyed to hospital following
treatment by the ambulance service for a
severe hypoglycaemic episode
R Atkinson1, L Bryant2, L Spratling2, N Basudev2, C Gosling1
and N Patel1,2
1Diabetes and Endocrine, Guy’s & St Thomas’ NHS Trust, London, UK,
2Diabetes, South London Health Innovation Network, London, UK
Introduction: A three month retrospective audit identified 3 out
of 6 patients treated for a hypoglycaemic episode by the ambulance
service were not conveyed to hospital.
Aim: To assess the feasibility of an integrated pathway between
ambulance service, acute diabetes trust, patients and general
practice.
Objectives: Measure numbers referred over 3 months
Identify outcome of the telephone consultation
Identify intervention
Ascertain onward referral
Identify resources required and potential savings
Method: Project group agreed design, clinical governance
accountability and consent for alteration in service contract for
the pilot period
The ambulance service forwarded a hypo notification
A specialist diabetes nurse made telephone contact within 42h
On completion the hypo notification and consultation outcome
was sent to the general practitioner
Results: 11 referrals, 10 successful telephone contacts
Classification
Type 1 diabetes – six patients
Type 2 diabetes – four patients
Pancreatitis - one patient
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